Cargando…

Terbium-149 for targeted alpha therapy

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Grundler, Pascal, Johnston, Karl, Koester, Ulli, Mueller, Cristina, Talip, Zeynap, van der Meulen, Nick
Publicado:	2023
Materias:	Detectors and Experimental Techniques
Acceso en línea:	http://cds.cern.ch/record/2845998

Ejemplares similares

Terbium-149 for targeted alpha therapy
por: Borgna, Francesca, et al.
Publicado: (2021)

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
por: Müller, Cristina, et al.
Publicado: (2016)

Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014)

Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014)

IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Koester, Ulli, et al.
Publicado: (2018)

Targeted cancer therapy: the potential role of terbium-149
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1996)

Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2019)

Alpha-PET for Prostate Cancer: Preclinical investigation using (149)Tb-PSMA-617
por: Umbricht, Christoph A., et al.
Publicado: (2019)

Terbium-161 for PSMA-targeted radionuclide therapy of prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019)

Preclinical in vivo application of $^{152}$Tb-DOTANOC: a radiolanthanide for PET imaging
por: Müller, Cristina, et al.
Publicado: (2016)

Precise activity measurements of medical radionuclides using an ionization chamber: a case study with Terbium-161
por: Juget, Frédéric, et al.
Publicado: (2022)

Cyclotron production and radiochemical purification of terbium-155 for SPECT imaging
por: Favaretto, C., et al.
Publicado: (2021)

Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
por: Borgna, Francesca, et al.
Publicado: (2021)

149th SPSC Meeting
Publicado: (2023)

149th LHCC Meeting
Publicado: (2022)

Minutes of the 149th Meeting of the LHCC
por: CERN. Geneva. Large Hadron Collider Experiments Committee, et al.
Publicado: (2022)

Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with $^152$Tb-DOTATOC
por: Baum, Richard P, et al.
Publicado: (2017)

Off-line separation of reactor produced $^{169}$Er for medical applications
por: Formento Cavaier, Roberto, et al.
Publicado: (2017)

Temperature effects on alpha radioactivity of $^{223}$Ra
por: Huber, Gerhard, et al.
Publicado: (2006)

Agenda of the 149th Meeting of the SPSC, 10 and 11 May 2023
por: CERN. Geneva. SPS and PS Experiments Committee, et al.
Publicado: (2023)

Minutes of the 149th Meeting of the SPSC, Wednesday 10 and Thursday 11 May 2023
por: CERN. Geneva. SPS and PS Experiments Committee, et al.
Publicado: (2023)

Agenda of the 149th LHCC Meeting - Wednesday 9 and Thursday 10 March, 2022
por: CERN. Geneva. Large Hadron Collider Experiments Committee, et al.
Publicado: (2022)

Study of the kinetics of complex formation and in vivo stability of novel radiometal-chelate conjugates for applications in nuclear medicine
por: Radchenko, Valery, et al.
Publicado: (2017)

Digital TDPAC with rare earth isotope $^{169}$Yb, $^{147}$Gd, and $^{149}$Gd in Yb and Gd Doped CeO$_{2}$ and $^{147}$Gd in GdBa$_{2}$ Cu$_{3}$ O$_{7−\delta}$
por: Roeder, Jens, et al.
Publicado: (2011)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Domnanich, Katharina, et al.
Publicado: (2014)

Confirmation of the proposals T 148 - T 149 $K^{+}p$ and $K^{+}d$ experiments at 16 GeV/c
por: Müller, F
Publicado: (1968)

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application
por: Müller, Cristina, et al.
Publicado: (2018)

(161)Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of (161)Tb into the Clinic
por: Favaretto, Chiara, et al.
Publicado: (2023)

IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Köster, Ulli
Publicado: (2017)

Simultaneous Visualization of (161)Tb- and (177)Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging
por: Borgna, Francesca, et al.
Publicado: (2021)

Investigation of $\alpha$-decay rates of $^{221}$Fr, $^{224}$Ra and $^{226}$Ra in different environments.
por: Jeppesen, H B, et al.
Publicado: (2006)

Proposal to the ISRC: p-$\alpha$ and $\alpha$-$\alpha$ collisions in the ISR
por: Faessler, M A, et al.
Publicado: (1979)

Memorandum: Alpha-Alpha runs at the ISR
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1981)

Addendum to the ALPHA Proposal; The ALPHA-g Apparatus
por: Hangst, Jeffrey S
Publicado: (2016)

ALPHA Proposal
por: Hangst, Jeffrey S, et al.
Publicado: (2005)

Resonant laser ionization of polonium at RILIS-ISOLDE for the study of ground- and isomer-state properties
por: Cocolios, Thomas E, et al.
Publicado: (2008)

Spectroscopic and gravitational measurements on antihydrogen: ALPHA-3, ALPHA-g and beyond
por: Hangst, JS Aarhus University
Publicado: (2019)

Yield measurements for lanthanide elements with Ta-foil target and a LIST ion source
por: Chrysalidis, Katerina, et al.
Publicado: (2023)

The ALPHA antihydrogen trapping apparatus
por: Amole, C, et al.
Publicado: (2014)

Active bone marrow S-values for the low-energy electron emitter terbium-161 compared to S-values for lutetium-177 and yttrium-90
por: Hemmingsson, Jens, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t4ikt39fevifhkv0kms7nn6h2t